Futurum’s principal analyst Daniel Newman breaks down the news of Groq’s appointment of former Amazon leader, Raju Gulabani, to its Board of Directors. Newman also shares insights on what this means for the future of the startup.
Groq Turbocharges COVID Drug Discovery at Argonne National Laboratory
Groq demonstrates its technology enabled the acceleration of compute timelines from days to seconds at Argonne National Laboratory in its COVID drug discovery initiative. Futurum’s Ron Westfall assesses why Groq potentially gains a significant sales and marketing boost from its Argonne National Laboratory collaboration, especially in demonstrating the Groq solutions performance advantage over established GPU products as well as potentially fulfilling compute acceleration for an expanding array of AI and machine learning use cases and missions.